Detection of Very Low-Level Somatic Mosaic Splicing Variant in Asymptomatic Female Using Droplet Digital PCR

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Apr 1

PMID 35360741

Authors

Haiyue Deng

Yanqin Zhang

Jie Ding

Fang Wang

Affiliations

Soon will be listed here.

Abstract

Background: Alport syndrome is a hereditary glomerulopathy featured by haematuria, proteinuria, and progressive renal failure. X-linked Alport syndrome (XLAS) due to disease-causing variants is the most common form. In the case of XLAS resulting from 10-18% presumed disease-causing variants, there are only a few studies for mosaicism in the probands or parents. Very low-level (<1.0%) somatic mosaicism for disease-causing variants has not been published.

Materials And Methods: Chinese XLAS families with suspected parental mosaicism were enrolled in the present study to evaluate the forms of mosaicism, to offer more appropriate genetic counseling. PCR and direct sequencing were used to detect disease-causing variants harbored by the affected probands in parental multi-tissue DNAs (peripheral blood, urine sediments, saliva, hair), and droplet digital PCR (ddPCR) was used to quantify the mutant allelic fractions in parental different samples such as peripheral blood, saliva, and urine sediments.

Results: A Chinese asymptomatic female with suspected somatic and germline mosaicism was enrolled in the present study. She gave birth to two boys with XLAS caused by a hemizygous disease-causing variant c. 2245-1G>A in (NM_033380) intron 28, whereas this disease-causing variant was not detected in genomic DNA extracted from peripheral blood leukocytes in the woman using Sanger sequencing. She had multiple normal urine test results, and continuous linear immunofluorescence staining of α2 (IV) and α5 (IV) chains of skin tissue. Sanger sequencing demonstrated that disease-causing variant c. 2245-1G>A was not detected in her genomic DNAs isolated from urine sediments, saliva, and hair roots. Using ddPCR, the wild-type and mutant-type (c.2245-1G>A) was identified in the female's genomic DNAs isolated from peripheral blood, saliva, and urine sediments. The mutant allelic fractions in these tissues were 0.26% (peripheral blood), 0.73% (saliva), and 1.39% (urine), respectively.

Conclusions: Germline and very low-level somatic mosaicism for a splicing variant was detected in an asymptomatic female, which highlights that parental mosaicism should be excluded when a presumed disease-causing variant is detected.

References

Watanabe M, Kawaguchi T, Isa S, Ando M, Tamiya A, Kubo A . Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. Clin Cancer Res. 2015; 21(15):3552-60. DOI: 10.1158/1078-0432.CCR-14-2151. View

Lu B, Zeng F, Xing W, Liang L, Huo J, Tan C . Decreased mitochondrial DNA copy number in children with cerebral palsy quantified by droplet digital PCR. Clin Chim Acta. 2020; 503:122-127. DOI: 10.1016/j.cca.2020.01.018. View

Bu L, Chen J, Nelson A, Katz A, Kashtan C, Kim Y . Somatic Mosaicism in a Male Patient With X-linked Alport Syndrome. Kidney Int Rep. 2019; 4(7):1031-1035. PMC: 6609819. DOI: 10.1016/j.ekir.2019.03.005. View

Helle O, Pedersen T, Ousager L, Thomassen M, Hertz J . Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome. Mol Genet Genomic Med. 2020; 8(10):e1452. PMC: 7549549. DOI: 10.1002/mgg3.1452. View

Rheault M . Women and Alport syndrome. Pediatr Nephrol. 2011; 27(1):41-6. PMC: 3223569. DOI: 10.1007/s00467-011-1836-7. View

Spinner N, Conlin L . Mosaicism and clinical genetics. Am J Med Genet C Semin Med Genet. 2014; 166C(4):397-405. DOI: 10.1002/ajmg.c.31421. View

Fu X, Nozu K, Kaito H, Ninchoji T, Morisada N, Nakanishi K . Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet. 2015; 24(3):387-91. PMC: 4755365. DOI: 10.1038/ejhg.2015.113. View

Yokota K, Nozu K, Minamikawa S, Yamamura T, Nakanishi K, Kaneda H . Female X-linked Alport syndrome with somatic mosaicism. Clin Exp Nephrol. 2016; 21(5):877-883. DOI: 10.1007/s10157-016-1352-y. View

Jais J, Knebelmann B, Giatras I, Marchi M, Rizzoni G, Renieri A . X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol. 2003; 14(10):2603-10. DOI: 10.1097/01.asn.0000090034.71205.74. View

10.

Lemmink H, Schroder C, Monnens L, Smeets H . The clinical spectrum of type IV collagen mutations. Hum Mutat. 1997; 9(6):477-99. DOI: 10.1002/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#. View

11.

Wang F, Zhu L, Liu B, Zhu X, Wang N, Deng T . Noninvasive and Accurate Detection of Hereditary Hearing Loss Mutations with Buccal Swab Based on Droplet Digital PCR. Anal Chem. 2018; 90(15):8919-8926. DOI: 10.1021/acs.analchem.8b01096. View

12.

Cornec-Le Gall E, Audrezet M, Le Meur Y, Chen J, Ferec C . Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Hum Mutat. 2014; 35(12):1393-406. DOI: 10.1002/humu.22708. View

13.

Yang X, Liu A, Xu X, Yang X, Zeng Q, Ye A . Genomic mosaicism in paternal sperm and multiple parental tissues in a Dravet syndrome cohort. Sci Rep. 2017; 7(1):15677. PMC: 5688122. DOI: 10.1038/s41598-017-15814-7. View

14.

Lupski J . Genetics. Genome mosaicism--one human, multiple genomes. Science. 2013; 341(6144):358-9. DOI: 10.1126/science.1239503. View

15.

Depienne C, Arzimanoglou A, Trouillard O, Fedirko E, Baulac S, Saint-Martin C . Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat. 2006; 27(4):389. DOI: 10.1002/humu.9419. View

16.

Biesecker L, Spinner N . A genomic view of mosaicism and human disease. Nat Rev Genet. 2013; 14(5):307-20. DOI: 10.1038/nrg3424. View

17.

Gibson J, Fieldhouse R, Chan M, Sadeghi-Alavijeh O, Burnett L, Izzi V . Prevalence Estimates of Predicted Pathogenic Variants in a Population Sequencing Database and Their Implications for Alport Syndrome. J Am Soc Nephrol. 2021; 32(9):2273-2290. PMC: 8729840. DOI: 10.1681/ASN.2020071065. View

18.

Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T . A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2018; 23(2):158-168. PMC: 6510800. DOI: 10.1007/s10157-018-1629-4. View

19.

Lagona E, Tsartsali L, Kostaridou S, Skiathitou A, Georgaki E, Sotsiou F . Skin biopsy for the diagnosis of Alport syndrome. Hippokratia. 2008; 12(2):116-8. PMC: 2464308. View

20.

Liu A, Yang X, Yang X, Wu Q, Zhang J, Sun D . Mosaicism and incomplete penetrance of mutations. J Med Genet. 2018; 56(2):81-88. PMC: 6581080. DOI: 10.1136/jmedgenet-2017-105235. View